Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Price, John
Waller, Patrick
Wood, Susan
and
MacKay, Angus
1992.
Safety of fluoxetine: Comparison with fluvoxamine.
Pharmacoepidemiology and Drug Safety,
Vol. 1,
Issue. 3,
p.
111.
M. van Praag, Herman
1992.
About the centrality of mood lowering in mood disorders.
European Neuropsychopharmacology,
Vol. 2,
Issue. 4,
p.
393.
Verhoeven, WillemM.A.
Tuinier, Siegfried
Sijben, A.S.
Van Den Berg, YvonneW.H.M.
De Witte-van der Schoot, E.P.P.M.
Pepplinkhuizen, Lolke
and
Van Nieuwenhuizen, Onno
1992.
Eltoprazine in mentally retarded self-injuring patients.
The Lancet,
Vol. 340,
Issue. 8826,
p.
1037.
Kennedy, H. G.
1992.
Anger and Irritability.
British Journal of Psychiatry,
Vol. 161,
Issue. 2,
p.
145.
Virkkunen, Matti
1992.
Brain serotonin and violent behaviour.
The Journal of Forensic Psychiatry,
Vol. 3,
Issue. 1,
p.
171.
C. Cath, D.
van de Wetering, B. J. M.
A. Hoogduin, C.
Roos, R. A. C.
and
van Woerkom., T. C. A. M.
1992.
Het syndroom van Gilles de la Tourette en obsessief–compulsieve stoornissen: drang en dwang vergeleken.
Dth,
Vol. 12,
Issue. 4,
p.
177.
Power, A. C.
and
Cowen, P. J.
1992.
Fluoxetine and Suicidal Behaviour.
British Journal of Psychiatry,
Vol. 161,
Issue. 6,
p.
735.
Brown, Serena-Lynn
Botsis, Alexander J.
and
Van Praag, Herman M.
1992.
Suicide: CSF and neuroendocrine challenge studies.
International Review of Psychiatry,
Vol. 4,
Issue. 2,
p.
141.
Sandyk, Reuven
and
Awerbuch, Gavin I
1993.
Nocturnal Melatonin Secretion in Suicidal Patients with Multiple Sclerosis.
International Journal of Neuroscience,
Vol. 71,
Issue. 1-4,
p.
173.
Sandyk, Reuven
and
Derpapas, Kyriakos
1993.
Magnetic Fields Normalize Visual Evoked Potentials and Brainstem Auditory Evoked Potentials in Multiple Sclerosis.
International Journal of Neuroscience,
Vol. 68,
Issue. 3-4,
p.
241.
Fenwick, Peter
1993.
Brain, Mind and Behaviour.
British Journal of Psychiatry,
Vol. 163,
Issue. 5,
p.
565.
Olivier, Berend
Mos, Jan
Raghoebar, Maikel
de Koning, Paul
and
Mak, Marianne
1994.
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques.
p.
167.
1994.
Central serotonergic hyperresponsivity in late-onset Alzheimer's disease.
American Journal of Psychiatry,
Vol. 151,
Issue. 11,
p.
1701.
Fichter, M. M.
Quadflieg, N.
and
Rief, W.
1994.
Course of multi-impulsive bulimia.
Psychological Medicine,
Vol. 24,
Issue. 3,
p.
591.
Hoffmann, P.
Elam, M.
Thorén, P.
and
Hjorth, S.
1994.
Effects of long-lasting voluntary running on the cerebral levels of dopamine, serotonin and their metabolites in the spontaneously hypertensive rat.
Life Sciences,
Vol. 54,
Issue. 13,
p.
855.
Kirby, Michael
and
Lawlor, Brian A.
1995.
Biologic Markers and Neurochemical Correlates of Agitation and Psychosis in Dementia.
Journal of Geriatric Psychiatry and Neurology,
Vol. 8,
Issue. 1,
p.
S2.
Brunner, Han G.
1995.
Monoamine Oxidase and Behaviour.
Annals of Medicine,
Vol. 27,
Issue. 4,
p.
431.
Bond, Alyson J.
Feizollah, Sabah
and
Lader, Malcolm H.
1995.
The effects of D-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function.
Journal of Psychopharmacology,
Vol. 9,
Issue. 1,
p.
1.
Sandyk, Reuven
1996.
Suicidal Behavior is Attenuated in Patientis with Multiple Sclerosis by Treatment with Electromagnetic Fields.
International Journal of Neuroscience,
Vol. 87,
Issue. 1-2,
p.
5.
Van Praag, H. M.
1996.
Comorbidity (Psycho) Analysed.
British Journal of Psychiatry,
Vol. 168,
Issue. S30,
p.
129.